Abstract
Introduction Nearly 80% of newly diagnosed and approximately 25% of relapsed testicular cancer patients can be cured using conventional combination chemotherapy with or without resection (Einhorn, 1997; Sonneveld et al., 2001).
| Original language | English |
|---|---|
| Title of host publication | The BMT Data Book |
| Subtitle of host publication | Including Cellular Therapy |
| Pages | 139-145 |
| Number of pages | 7 |
| ISBN (Electronic) | 9781139519205 |
| DOIs | |
| State | Published - Jan 1 2013 |
Bibliographical note
Publisher Copyright:© Cambridge University Press 2009 and 2013.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Therapeutic decision making in BMT/SCT for nonseminomatous germ cell tumor of testis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver